Colorado Blood Cancer Institute/SCRI — Denver, Colorado

Colorado Blood Cancer Institute/SCRI is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Colorado Blood Cancer Institute/SCRI has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Relapsed/Refractory Systemic Light Chain Amyloidosis, Multiple Myeloma.

Sponsors: Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Colorado Blood Cancer Institute/SCRI?

Colorado Blood Cancer Institute/SCRI has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Colorado Blood Cancer Institute/SCRI conducted?

Colorado Blood Cancer Institute/SCRI has 2 clinical trials on record, with 2 currently active. Their work covers Relapsed/Refractory Systemic Light Chain Amyloidosis, Multiple Myeloma.

Is Colorado Blood Cancer Institute/SCRI accredited by Crixeo Health?

Colorado Blood Cancer Institute/SCRI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Colorado Blood Cancer Institute/SCRI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.